Heidelberg Pharma, Wilex deal

Wilex will acquire Heidelberg in a stock deal valued at €19.2 million ($26.8 million). Wilex will issue 3.2 million shares valued at €6 per share, which is a 23% premium to Wilex's close of €4.87 on N...